| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| M Matsubara, E Odagaki, T Moriok. [Suppression by dopamine of GH release induced by GRF in a case of acromegaly]. Nihon Naibunpi Gakkai zasshi. vol 63. issue 3. 1987-09-02. PMID:3111898. |
[suppression by dopamine of gh release induced by grf in a case of acromegaly]. |
1987-09-02 |
2023-08-11 |
Not clear |
| M Matsubara, E Odagaki, T Moriok. [Suppression by dopamine of GH release induced by GRF in a case of acromegaly]. Nihon Naibunpi Gakkai zasshi. vol 63. issue 3. 1987-09-02. PMID:3111898. |
inhibition of plasma gh by dopaminergic agonists is one of the characteristics of the gh secretion in acromegaly. |
1987-09-02 |
2023-08-11 |
Not clear |
| M Matsubara, E Odagaki, T Moriok. [Suppression by dopamine of GH release induced by GRF in a case of acromegaly]. Nihon Naibunpi Gakkai zasshi. vol 63. issue 3. 1987-09-02. PMID:3111898. |
grf is known to stimulate gh secretion in most patients with acromegaly. |
1987-09-02 |
2023-08-11 |
Not clear |
| G Sampaolo, E Faloia, R Sarzani, V Bartolacci, P Schiavo, L Butini, P Morosini, V Barolacc. [GH and PRL after TRH and hpGRF(1-40) administration in 2 cases of acromegaly with hyperprolactinemia]. Recenti progressi in medicina. vol 78. issue 3. 1987-07-27. PMID:3110882. |
[gh and prl after trh and hpgrf(1-40) administration in 2 cases of acromegaly with hyperprolactinemia]. |
1987-07-27 |
2023-08-11 |
Not clear |
| R Horikawa, K Takano, N Hizuka, K Asakawa, T Shibasaki, A Masuda, K Shizum. Effect of a single administration of somatostatin analogue (SMS 201-995) on GH, TSH and insulin secretion in patients with acromegaly. Endocrinologia japonica. vol 33. issue 6. 1987-06-26. PMID:2884093. |
effect of a single administration of somatostatin analogue (sms 201-995) on gh, tsh and insulin secretion in patients with acromegaly. |
1987-06-26 |
2023-08-11 |
Not clear |
| R Horikawa, K Takano, N Hizuka, K Asakawa, T Shibasaki, A Masuda, K Shizum. Effect of a single administration of somatostatin analogue (SMS 201-995) on GH, TSH and insulin secretion in patients with acromegaly. Endocrinologia japonica. vol 33. issue 6. 1987-06-26. PMID:2884093. |
our results show that the new somatostatin analogue sms 201-995 may inhibit gh hypersecretion in acromegalic patients for significant periods, suggesting that this agent can be a useful clinical tool for the treatment of acromegaly. |
1987-06-26 |
2023-08-11 |
Not clear |
| M Giusti, A Lomeo, M Monachesi, G Mazzocchi, R Attanasio, P Sessarego, D Mignone, P Del Monte, G Giordan. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy. Journal of endocrinological investigation. vol 10. issue 2. 1987-06-26. PMID:3108356. |
the ghrh test may represent a new tool in the study of gh dynamics in acromegaly. |
1987-06-26 |
2023-08-11 |
human |
| M Giusti, A Lomeo, M Monachesi, G Mazzocchi, R Attanasio, P Sessarego, D Mignone, P Del Monte, G Giordan. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy. Journal of endocrinological investigation. vol 10. issue 2. 1987-06-26. PMID:3108356. |
in acromegaly, gh responses after ghrh (p less than 0.01 vs placebo) were variable. |
1987-06-26 |
2023-08-11 |
human |
| M Giusti, A Lomeo, M Monachesi, G Mazzocchi, R Attanasio, P Sessarego, D Mignone, P Del Monte, G Giordan. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy. Journal of endocrinological investigation. vol 10. issue 2. 1987-06-26. PMID:3108356. |
maximum gh increase after ghrh (calculated as peak/basal value ratio) was significantly reduced in acromegaly (2.9 +/- 0.5 ng/ml; mean +/- se) in comparison to controls (34.1 +/- 10.9 ng/ml; p less than 0.01). |
1987-06-26 |
2023-08-11 |
human |
| T Inoue, N Watanabe, S Saito, M Yamasaki, H Saito, N Shirakaw. Determination of insulin-like growth factor-I in normal subjects and in patients with growth hormone disorders by radioimmunoassay using biosynthetic homologous peptide. Endocrinologia japonica. vol 33. issue 6. 1987-06-26. PMID:3582270. |
as reported by others, the igf-i levels were low in cord plasma (41.8 +/- 23.5 ng/ml) and plasma of patients with gh deficiency (64.6 +/- 42.0 ng/ml), while its levels were high in normal children of pubertal ages (12-13 yr, 365 +/- 126 ng/ml) and in patients with active acromegaly (562 +/- 115 ng/ml). |
1987-06-26 |
2023-08-11 |
human |
| A Klibanski, N T Zervas, K Kovacs, E C Ridgwa. Clinically silent hypersecretion of growth hormone in patients with pituitary tumors. Journal of neurosurgery. vol 66. issue 6. 1987-06-22. PMID:3572509. |
hypersecretion of growth hormone (gh) was found in three women aged 25 to 35 years old, with somatotroph adenomas without clinical stigmata of acromegaly. |
1987-06-22 |
2023-08-11 |
human |
| P G Chiodini, R Cozzi, D Dallabonzana, G Oppizzi, G Verde, M Petroncini, A Liuzzi, E del Poz. Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine. The Journal of clinical endocrinology and metabolism. vol 64. issue 3. 1987-03-31. PMID:2880861. |
the clinical and metabolic parameters of acromegaly dramatically improved in all patients whose plasma gh and somatomedin-c levels decreased even if they were not normalized by sms. |
1987-03-31 |
2023-08-11 |
Not clear |
| F Gómez, F Steinhäuslin, B Crottaz, E Temle. [Anterior pituitary hypersecretion syndromes]. Schweizerische medizinische Wochenschrift. vol 117. issue 3. 1987-03-30. PMID:3029861. |
the etiology of acromegaly is a growth hormone (gh)-secreting pituitary tumor in the vast majority of cases. |
1987-03-30 |
2023-08-11 |
Not clear |
| R Boizel, S Halimi, F Labat, R Cohen, I Bachelo. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment. The Journal of clinical endocrinology and metabolism. vol 64. issue 2. 1987-02-19. PMID:3098773. |
we studied gh secretion in a patient with acromegaly and a bronchial carcinoid tumor before and again after surgical removal of this tumor. |
1987-02-19 |
2023-08-11 |
Not clear |
| K Hanew, A Sasaki, S Sato, M Goh, K Yoshinag. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly. The Journal of clinical endocrinology and metabolism. vol 64. issue 2. 1987-02-19. PMID:3793848. |
it is not clear whether dopamine (da) has a central stimulating activity on gh secretion in patients with acromegaly, as it does in normal subjects. |
1987-02-19 |
2023-08-11 |
human |
| K Hanew, A Sasaki, S Sato, M Goh, K Yoshinag. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly. The Journal of clinical endocrinology and metabolism. vol 64. issue 2. 1987-02-19. PMID:3793848. |
to clarify this, we compared the gh inhibitory potencies of da, which does not cross the blood-brain barrier (bbb), and l-dopa or bromocriptine, which do cross the bbb, in 23 patients with acromegaly. |
1987-02-19 |
2023-08-11 |
human |
| K Hanew, A Sasaki, S Sato, M Goh, K Yoshinag. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly. The Journal of clinical endocrinology and metabolism. vol 64. issue 2. 1987-02-19. PMID:3793848. |
these results suggest that in acromegaly, da has not only direct suppressive effects on the pituitary tumor somatotrophs, but also indirect stimulatory effects via the hypothalamus; therefore, the hypothalamic gh-releasing system is not entirely suppressed by excessive tumor gh secretion. |
1987-02-19 |
2023-08-11 |
human |
| G Benker, B Gieshoff, O Freundlieb, R Windeck, H M Schulte, I Lancranjan, D Reinwei. Parenteral bromocriptine in the treatment of hormonally active pituitary tumours. Clinical endocrinology. vol 24. issue 5. 1987-02-06. PMID:3791649. |
in one patient with acromegaly gh plasma levels decreased into the normal range. |
1987-02-06 |
2023-08-11 |
Not clear |
| M C White, P Newland, M Daniels, S J Turner, D Mathias, G Teasdale, P Kendall-Taylo. Growth hormone secreting pituitary adenomas are heterogeneous in cell culture and commonly secrete glycoprotein hormone alpha-subunit. Clinical endocrinology. vol 25. issue 2. 1987-02-05. PMID:2431811. |
cell culture methods were used to assess whether human pituitary adenomas secreting gh and associated with clinical acromegaly also secreted the structurally unrelated glycoprotein hormone alpha-subunit. |
1987-02-05 |
2023-08-11 |
human |
| M C White, P Newland, M Daniels, S J Turner, D Mathias, G Teasdale, P Kendall-Taylo. Growth hormone secreting pituitary adenomas are heterogeneous in cell culture and commonly secrete glycoprotein hormone alpha-subunit. Clinical endocrinology. vol 25. issue 2. 1987-02-05. PMID:2431811. |
these cell culture studies would suggest that pituitary adenomas causing acromegaly are hormonally heterogeneous and that prl and glycoprotein alpha-subunit are commonly detected in addition to gh. |
1987-02-05 |
2023-08-11 |
human |